Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Lazar

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|November 6, 1990
Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockadeW H Frishman, E J Lazar
Journal of Cardiovascular Pharmacology|January 1, 1988
Calcium channel blockers in patients with both hypertension and angina pectorisW H Frishman, E J Lazar
Journal of Clinical Pharmacology|May 1, 1992
Sustained-release verapamil formulations for treating hypertensionW H Frishman, E J Lazar
Drugs|January 1, 1989
Profile of an ideal antianginal agentE J Lazar, W H Frishman
Clinical Pharmacokinetics|April 1, 1991
Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agentsW H Frishman, E J Lazar, G Gorodokin
Geriatrics|July 1, 1992
Angina pectoris and silent ischemia in the elderly: a management updateE J Lazar, J M Lazar, W Frishman
The Journal of Allergy and Clinical Immunology|May 1, 1988
A bronchodilator action of glucagonM S Sherman, E J Lazar, P Eichacker
Archives of Internal Medicine|December 1, 1984
Severe hyperkalemia during piroxicam therapyK P Miller, E J Lazar, S Fotino
Cardiology Clinics|February 1, 1991
Medical therapy of the hypertensive patient with concomitant angina pectorisE J Lazar, W H Frishman, N Grover
International Journal of Cardiology|December 1, 1987
Restrictive-type hemodynamics following valve surgery for rheumatic heart diseaseW Sherman, E J Lazar, B Goldman, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|November 6, 1990
Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockadeW H Frishman, E J Lazar
Journal of Cardiovascular Pharmacology|January 1, 1988
Calcium channel blockers in patients with both hypertension and angina pectorisW H Frishman, E J Lazar
Journal of Clinical Pharmacology|May 1, 1992
Sustained-release verapamil formulations for treating hypertensionW H Frishman, E J Lazar
Drugs|January 1, 1989
Profile of an ideal antianginal agentE J Lazar, W H Frishman
Clinical Pharmacokinetics|April 1, 1991
Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agentsW H Frishman, E J Lazar, G Gorodokin
Geriatrics|July 1, 1992
Angina pectoris and silent ischemia in the elderly: a management updateE J Lazar, J M Lazar, W Frishman
The Journal of Allergy and Clinical Immunology|May 1, 1988
A bronchodilator action of glucagonM S Sherman, E J Lazar, P Eichacker
Archives of Internal Medicine|December 1, 1984
Severe hyperkalemia during piroxicam therapyK P Miller, E J Lazar, S Fotino
Cardiology Clinics|February 1, 1991
Medical therapy of the hypertensive patient with concomitant angina pectorisE J Lazar, W H Frishman, N Grover
International Journal of Cardiology|December 1, 1987
Restrictive-type hemodynamics following valve surgery for rheumatic heart diseaseW Sherman, E J Lazar, B Goldman, et al.
Pageof 3